Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Nicholas Zareifopoulos, Aggeliki Bellou, Agathi Spiropoulou & Kostas Spiropoulos. (2019) Prevalence, Contribution to Disease Burden and Management of Comorbid Depression and Anxiety in Chronic Obstructive Pulmonary Disease: A Narrative Review. COPD: Journal of Chronic Obstructive Pulmonary Disease 16:5-6, pages 406-417.
Read now
Read now
Nurdan Kokturk, Wael Abuharbid, Amr S Albanna, Hakan Gunen, Alev Gurgun, Mousa Khadadah, Elmas Malvolti, Medhat Soliman, Richard van Zyl-Smit, Noureddine Zidouni & Ashraf Alzaabi. (2019) A Cross-Sectional Study in Patients with Severe COPD to Assess the Perception of Symptom Variability (COPVAR) in the Middle East and Africa. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 2959-2970.
Read now
Read now
Eulogio Pleguezuelos, Paula Casarramona, Lluis Guirao, Beatriz Samitier, Pilar Ortega, Xavier Vila, Amin Del Carmen, Laura Ovejero, Eva Moreno, Noemi Serra, Manuel Gomís, Manuel V Garnacho-Castaño & Marc Miravitlles. (2018) How whole-body vibration can help our COPD patients. Physiological changes at different vibration frequencies. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 3373-3380.
Read now
Read now
Craig LaForce, Eric Derom, Ulrich Bothner, Isabel M Kloer, Matthias Trampisch & Roland Buhl. (2018) Long-term safety of tiotropium/olodaterol Respimat® in patients with moderate-to-very severe COPD and renal impairment in the TONADO® studies. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 1819-1831.
Read now
Read now
Anthony D D’Urzo, Peter Kardos & Russell Wiseman. (2018) Practical considerations when prescribing a long-acting muscarinic antagonist for patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 1089-1104.
Read now
Read now
Amnon Ariel, Alan Altraja, Andrey Belevskiy, Piotr W Boros, Edvardas Danila, Matjaz Fležar, Vladimir Koblizek, Zvi G Fridlender, Kosta Kostov, Alvils Krams, Branislava Milenkovic, Attila Somfay, Ruzena Tkacova, Neven Tudoric, Ruxandra Ulmeanu & Arschang Valipour. (2018) Inhaled therapies in patients with moderate COPD in clinical practice: current thinking. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 45-56.
Read now
Read now
Articles from other publishers (15)
Chun-Chao Chen, Cheng-Hsin Lin, Wen-Rui Hao, Chun-Chih Chiu, Yu-Ann Fang, Ju-Chi Liu & Li-Chin Sung. (2021) Association between chronic obstructive pulmonary disease and ventricular arrhythmia: a nationwide population-based cohort study. npj Primary Care Respiratory Medicine 31:1.
Crossref
Crossref
Antonio Anzueto & Marc Miravitlles. (2020) Tiotropium in chronic obstructive pulmonary disease – a review of clinical development. Respiratory Research 21:1.
Crossref
Crossref
Jeong-Il Kang & Dae-Keun Jeong. (2020) Effects of Squat Exercise Combined with Whole-Body Vibration on the Pulmonary Function and the Quadriceps Femoris Activity of Patients with Severe Chronic Obstructive Pulmonary Disease. Journal of The Korean Society of Physical Medicine 15:4, pages 121-129.
Crossref
Crossref
Beth Hahn, Richard H. Stanford, Alyssa Goolsby Hunter, Breanna Essoi, John White & Riju Ray. (2019) Patient-Reported Burden of Illness in a Prevalent COPD Population Treated with Long-Acting Muscarinic Antagonist Monotherapy: A Claims-Linked Patient Survey Study. Pulmonary Therapy 5:1, pages 69-80.
Crossref
Crossref
Marc Miravitlles, Nicolas Roche, João Cardoso, David Halpin, Zaurbek Aisanov, Hannu Kankaanranta, Vladimir Kobližek, Paweł Śliwiński, Leif Bjermer, Michael Tamm, Francesco Blasi & Claus F. Vogelmeier. (2018) Chronic obstructive pulmonary disease guidelines in Europe: a look into the future. Respiratory Research 19:1.
Crossref
Crossref
Eulogio Pleguezuelos, Lluis Guirao, Eva Moreno, Beatriz Samitier, Pilar Ortega, Xavier Vila, Manuel V. Garnacho-Castaño, María Majó, Laura Ovejero & Marc Miravitlles. (2018) Ischiocrural Strength May Be a Better Prognostic Marker Than Quadriceps Strength in COPD. Lung 196:6, pages 665-668.
Crossref
Crossref
François Savaria, Marie-France Beauchesne, Amélie Forget & Lucie Blais. (2017) Polypharmacy, chronic kidney disease, and benign prostatic hyperplasia in patients with chronic obstructive pulmonary disease newly treated with long-acting anticholinergics. Respiratory Medicine 132, pages 195-202.
Crossref
Crossref
David M. Halpin, Alan G. Kaplan & Richard K. Russell. (2017) Why choose tiotropium for my patient? A comprehensive review of actions and outcomes versus other bronchodilators. Respiratory Medicine 128, pages 28-41.
Crossref
Crossref
Z.D. Semidotska, I.A. Chernyakova, O.M. Pionova & N.S. Tryfonova. (2016) http://www.internalmed-journal.in.ua/en/archives/910. Shidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini 2016:2, pages 4-12.
Crossref
Crossref
Ashraf Z. Mohamed, Ahmad M. Moharrm, Maha K. Ghanem, Hoda A. Makhlouf, Ebtesam M. El-Gezawy & Sahar F. Youssif. (2016) Role of comorbidities in acquiring pulmonary fungal infection in chronic obstructive pulmonary disease patients. Egyptian Journal of Bronchology 10:3, pages 243-250.
Crossref
Crossref
Nanshan Zhong, Hwa S. Moon, Kwan H. Lee, Aziah A. Mahayiddin, Watchara Boonsawat, Marie G.D. Isidro, ChunXue Bai, Achim Mueller, Norbert Metzdorf & Antonio Anzueto. (2016)
TIOtropium
Safety and Performance In Respimat
®
(TIOSPIR
TM
): Analysis of Asian cohort of
COPD
patients
. Respirology 21:8, pages 1397-1403.
Crossref
Crossref
Donald P. Tashkin, Eric D. Bateman, Paul Jones, Valentina B. Zubek, Norbert Metzdorf, Dacheng Liu, Thomas Leonard, Emmanuelle Clerisme-Beaty & Robert A. Wise. (2016) Consistent improvement in health-related quality of life with tiotropium in patients with chronic obstructive pulmonary disease: Novel and conventional responder analyses. Respiratory Medicine 120, pages 91-100.
Crossref
Crossref
Robert Wise, Antonio Anzueto, Ronald Dahl, Daniel Dusser & Peter Calverley. (2016) Tiotropium safety in ‘real‐world’ populations. British Journal of Clinical Pharmacology 82:2, pages 562-563.
Crossref
Crossref
Sven Schmiedl, Petra Thürmann, Rainald Fischer, Dominik Rottenkolber & Marietta Rottenkolber. (2016)
Response to Wise
et al
. (Tiotropium safety in real life populations)
. British Journal of Clinical Pharmacology 82:2, pages 564-565.
Crossref
Crossref
R. W. Dal Negro, L. Bonadiman & P. Turco. (2015) Prevalence of different comorbidities in COPD patients by gender and GOLD stage. Multidisciplinary Respiratory Medicine 10:1.
Crossref
Crossref